Skip to main content
. 2011 May 23;32(8):1216–1222. doi: 10.1093/carcin/bgr095

Table III.

SNP associations with NET in the discovery and replication sets (selected SNPs are those associated with NET risk in the discovery set with adjusteda P-value under 0.01)

Gene Variable Discovery set (n = 261 cases, 319 controls)
Replication set (n = 235 cases, 113 controls)
Dominant aOR* (95% CI) Dominant P-value Additive aOR* (95% CI) Additive P-value HWE-P Dominant aOR* (95% CI) Dominant P-value Additive aORa (95% CI) Additive P-value HWE-P
TSC2 rs13337626 2.82 (1.89, 4.19) 3.18E-07 2.46 (1.69, 3.57) 2.69E-06 0.50 Failed genotyping
IL1RN rs380092 1.87 (1.32, 2.65) 0.0004 1.65 (1.27, 2.15) 0.0002 0.61 0.61 (0.38, 0.98) 0.04 0.69 (0.49, 0.97) 0.03b 0.88
CYP1B1 rs162562 1.75 (1.23, 2.48) 0.002 1.51 (1.11, 2.04) 0.008 0.69 1.21 (0.75, 1.95) 0.44 1.20 (0.79, 1.82) 0.41 0.54
BIRC5 rs1508147 1.76 (1.22, 2.53) 0.002 1.37 (1.07, 1.76) 0.014 0.19 0.93 (0.57, 1.50) 0.75 0.92 (0.65, 1.29) 0.61 0.45
AKAP9 rs6964587 0.58 (0.41, 0.83) 0.003 0.70 (0.55, 0.91) 0.006 0.47 1.46 (0.89, 2.37) 0.13 1.27 (0.91, 1.77) 0.17 0.65
IL12A rs2243123 1.68 (1.18, 2.38) 0.004 1.43 (1.09, 1.89) 0.011 0.40 1.53 (0.97, 2.43) 0.07 1.47 (1.03, 2.12) 0.04 0.62
BCL2 rs7234941 0.58 (0.40, 0.84) 0.004 0.59 (0.42, 0.84) 0.013 0.04 1.21 (0.72, 2.02) 0.48 1.18 (0.74, 1.88) 0.48 0.37
APAF1 rs1007573 0.53 (0.34, 0.82) 0.004 0.60 (0.40, 0.90) 0.012 0.56 0.89 (0.48, 1.64) 0.70 0.99 (0.55, 1.64) 0.85 0.96
BCL2 rs1982673 0.57 (0.38, 0.85) 0.005 0.59 (0.42, 0.84) 0.003 0.50 Failed genotyping
DAD1 rs8005354 1.65 (1.15, 2.35) 0.006 1.31 (1.03, 1.67) 0.028 0.04 1.52 (0.96, 2.41) 0.07 1.43 (1.02, 2.02) 0.04 0.62
APAF1 rs2288713 0.55 (0.36, 0.85) 0.007 0.62 (0.42, 0.92) 0.018 0.60 0.90 (0.49, 1.68) 0.75 0.98 (0.55, 1.75) 0.94 0.29
CYP1B1 rs10916 1.62 (1.13, 2.30) 0.008 1.44 (1.06, 1.95) 0.019 0.70 Failed genotyping
MS4A6A rs1019670 0.67 (0.47, 0.95) 0.026 0.67 (0.52, 0.87) 0.002 0.72 1.00 (0.62, 1.62) 0.99 0.94 (0.68, 1.31) 0.73 0.47
FRAP1 rs12124983 1.52 (1.07, 2.14) 0.019 1.51 (1.16, 1.97) 0.002 0.10 0.83 (0.53, 1.32) 0.44 0.90 (0.63, 1.27) 0.53 0.67
CASP7 rs4342983 1.80 (1.14, 2.86) 0.013 1.85 (1.19, 2.89) 0.007 0.21 0.95 (0.48, 1.86) 0.87 0.92 (0.49, 1.73) 0.79 0.51
FRAP1 rs1064261 1.42 (1.01, 2.01) 0.05 1.45 (1.11, 1.90) 0.007 0.21 0.84 (0.53, 1.34) 0.46 0.99 (0.71, 1.37) 0.94 0.52
TERT rs2075786 1.38 (0.97, 1.97) 0.07 1.41 (1.10, 1.80) 0.007 0.73 1.47 (0.93, 2.33) 0.10 1.29 (0.87, 1.74) 0.25 0.68
ADH1C rs698 1.46 (1.02, 2.08) 0.04 1.38 (1.08, 1.77) 0.01 0.94 1.11 (0.68, 1.79) 0.68 1.14 (0.82, 1.59) 0.45 0.46

CI, confidence interval. SNPs considered to replicate in bold.

a

Adjusted for age, sex and smoking (discovery), adjusted for age and sex (replication).

b

Risk association in discovery and replication are in opposite directions, so not reported as replicating.